ANAB
ANAPTYSBIO, INC
NASDAQ · Healthcare · Biotechnology · US
$48.28
−0.74%Leverage
- Debt / equity
- 25.47x
- Net debt / equity
- 12.83x
- Debt / assets
- 0.85x
- Debt / EBITDA
- 2.93x
- Net debt / EBITDA
- 1.48x
Liquidity & coverage
- Current ratio
- 5.61x
- Quick ratio
- 5.61x
- Cash ratio
- 4.64x
- Interest coverage
- 1.61x
- EBITDA / interest
- 1.10x
- Working capital
- $163.1M
Cash & dividend
- FCF / debt
- 0.07x
- Cash flow / debt
- 0.07x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026